|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 767.40 INR | +2.86% |
|
-3.31% | +9.29% |
| Market Cap | 7.32B 76.88M 67.21M 61.76M 57.57M 109M 111M 741M 288M 3.6B 289M 282M 12.4B | P/E 2024 |
45.4x | P/E 2025 | 45.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.28B 76.43M 66.81M 61.4M 57.23M 109M 110M 737M 287M 3.58B 287M 281M 12.33B | EV / Sales 2024 |
4.69x | EV / Sales 2025 | 2.12x |
| Free-Float |
24.75% | Yield 2024 |
0.09% | Yield 2025 | 0.07% |
| 1 day | +2.86% | ||
| 1 week | -3.31% | ||
| Current month | -1.52% | ||
| 1 month | +7.82% | ||
| 3 months | +21.82% | ||
| 6 months | -0.20% | ||
| Current year | +9.29% |
| 1 week | 711 | 786 | |
| 1 month | 679 | 829 | |
| Current year | 580 | 937 | |
| 1 year | 580 | 993.95 | |
| 3 years | 378.75 | 1,417.38 | |
| 5 years | 213.91 | 1,417.38 | |
| 10 years | 213.91 | 1,417.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 38 | 2023-01-15 | |
Anjali Shah
DFI | Director of Finance/CFO | - | 2023-01-05 |
| Compliance Officer | - | 2023-01-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 38 | 2015-09-20 | |
| Chairman | 41 | 2015-09-20 | |
| Director/Board Member | 38 | 2015-09-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.86% | -3.31% | -19.58% | +54.06% | 93.96M | ||
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | ||
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | ||
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | ||
| +3.86% | +1.64% | +31.35% | +24.29% | 338B | ||
| -0.56% | +0.96% | +39.86% | +36.64% | 299B | ||
| -0.08% | +1.30% | +30.37% | +44.02% | 291B | ||
| -1.54% | +2.81% | -27.56% | -39.45% | 222B | ||
| +3.55% | +4.41% | +25.45% | +66.28% | 202B | ||
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | ||
| Average | +2.17% | +3.79% | +25.94% | +57.44% | 369.25B | |
| Weighted average by Cap. | +2.25% | +5.53% | +41.78% | +83.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.13B 22.36M 19.54M 17.96M 16.74M 31.75M 32.23M 216M 83.82M 1.05B 83.91M 82.11M 3.61B | 6.2B 65.15M 56.96M 52.34M 48.79M 92.54M 93.95M 628M 244M 3.05B 245M 239M 10.51B |
| Net income | 215M 2.26M 1.98M 1.82M 1.69M 3.21M 3.26M 21.82M 8.48M 106M 8.49M 8.31M 365M | 291M 3.05M 2.67M 2.45M 2.29M 4.34M 4.4M 29.45M 11.45M 143M 11.46M 11.21M 492M |
| Net Debt | -178M -1.87M -1.63M -1.5M -1.4M -2.65M -2.7M -18.03M -7.01M -87.49M -7.02M -6.87M -301M | -42.9M -451K -394K -362K -337K -640K -650K -4.35M -1.69M -21.09M -1.69M -1.65M -72.67M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ₹767.40 | +2.86% | 5,400 |
| 26-07-02 | ₹746.05 | +0.24% | 2,100 |
| 26-07-01 | ₹744.30 | -4.49% | 5,400 |
| 26-06-30 | ₹779.25 | +2.06% | 3,100 |
| 26-06-29 | ₹763.55 | -3.80% | 4,000 |
- Stock Market
- Stocks
- REMUS Stock
Select your edition
All financial news and data tailored to specific country editions
















